| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.007 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |